• Rani Therapeutics' (RANI) Buy Rating Reaffirmed at Canaccord Genuity Group

    Source: Buzz FX / 27 Feb 2025 12:01:20   America/Chicago


    Rani Therapeutics' (RANI) Buy Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat February 27, 2025 Share Link copied to clipboard. Rani Therapeutics ( NASDAQ:RANI - Get Free Report ) 's stock had its "buy" rating reissued by
    Read more...
Share on,